68Ga-BC1
- Generic Name
- 68Ga-BC1
A Molecular Probe Targeting BCMA for the Clinical Diagnosis of Multiple Myeloma
Early Phase 1
Not yet recruiting
- Conditions
- Multiple Myeloma and Malignant Plasma Cell Neoplasms
- Interventions
- First Posted Date
- 2024-12-04
- Last Posted Date
- 2025-04-04
- Lead Sponsor
- Peking University First Hospital
- Target Recruit Count
- 50
- Registration Number
- NCT06717113
- Locations
- 🇨🇳
Peking University First Hospital, Beijing, Beijing, China
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath